Developer docs
API playgroundTry for free, no card

Search company profiles

IMA Clinical Research

Full company profile

uuid000bntf

Namestring
IMA Clinical Research
Legal namestring
IMA Clinical Research
Websiteurl
imaresearch.com
Company typeenum
Private
Founded yearint
1995
Descriptiontext

IMA Clinical Research is a US-based, multisite clinical research site network operating as the dedicated clinical research division of The IMA Group, which was founded in 1995 by David C. Pulver, MD and has grown from a single office to 90+ offices across 20 states plus the District of Columbia. The company provides Phase II through Phase IV and post-market clinical trials to pharmaceutical sponsors and Contract Research Organizations, delivering trials through site-based, hybrid, and fully decentralized models across 90+ full-service sites and 150+ satellite locations. Its primary customer segments are pharmaceutical sponsors and CROs seeking diverse patient enrollment, rapid study startup, and high-quality data; patients seeking access to investigational treatments represent a secondary, indirect segment served through recruitment.

Core offerings include a fully integrated Clinical Trial Management System (CTMS) platform supporting centralized contracting, feasibility, budget development, IRB submissions, and accounting; a centralized Patient Outreach Center for longitudinal engagement with patients not typically reached onsite; a Patient Portal for remote participation management; and FlexBooker-integrated scheduling across locations. A stated 400K+ patient database with 10K+ unique patients seen weekly underpins recruitment and retention. Therapeutic coverage spans psychiatry, neurology, cardiometabolic, vaccines and infectious disease, gastrointestinal, pain, sleep, and digital therapeutics.

The business model is B2B fee-for-service clinical research, with revenue generated through study contracts negotiated directly with sponsors and CROs on a per-patient enrollment, milestone, and site-operational fee basis. The company is privately held (no public listing), headquartered in Tarrytown, NY (per the office locations data), has 501-1000 employees, and has executed three acquisitions — Clinical Trials of America (January 2023), Medical Research Network (2025), and Chicago Research Center (2025) — to expand CNS/psychiatric and Southeast US capabilities.

Short descriptiontext

IMA Clinical Research is a US multisite clinical research network within The IMA Group that runs Phase II-IV and decentralized clinical trials for pharmaceutical sponsors and CROs through 90+ full-service sites and 150+ satellite locations, supported by a 400K+ patient database.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersTarrytown, United States
HQ citystring
Tarrytown
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices14 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical trial services, clinical research sites, patient recruitment services, decentralized clinical trials, contract research organization
Industry3 codes
PRIMARYHLAGACAE
Clinical Trial Site Operations & Study Coordination
SECONDARYHLAGACAH
Decentralized & Hybrid Trial Site Services (Home Health/Nursing)
SECONDARYHLAGAAAI
Patient Recruitment, Site Feasibility & Trial Enablement CROs
NAICS code1 code
  • Scientific Research and Development Services5417
SIC code2 codes
  • Services-Commercial Physical & Biological Research8731
  • Services-Health Services8000
Product category
Clinical Research Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Clinical Research Services
TypeProfessional Services
Description

Fee-for-service clinical trial conduct providing Phase II-IV and post-market studies for pharmaceutical sponsors and CROs. Revenue generated through study contracts based on per-patient enrollment, study milestones, and site operational fees.

imaresearch.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

IMA Clinical Research operates a nationwide clinical trial site network providing Phase II-IV and post-market clinical study conduct for pharmaceutical sponsors and Contract Research Organizations (CROs). Services are delivered through site-based, hybrid, and fully decentralized trial models across 90+ full-service sites and 150+ satellite locations, leveraging a 400K+ patient database and a centralized Patient Outreach Center for enrollment and longitudinal engagement.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • High enrollment rates through access to 10K+ unique patients weekly
+3 more records
Product overview1 text field

IMA Clinical Research operates as a flexible clinical trial site network offering site-based, hybrid, and fully decentralized clinical trials. The network consists of 15+ full-service clinical trial sites and 150+ satellite locations across the United States, providing access to over 400,000 patients in a rapidly growing database. Key offerings include: the core IMA Clinical Research Network platform with a fully integrated CTMS for centralized contracting, budgeting, and study management; the Patient Outreach Center for longitudinal patient engagement; a Patient Portal for remote participation management; and comprehensive therapeutic research across psychiatry, neurology, cardiometabolic conditions, vaccines, and other specialties. The company has expanded through strategic acquisitions including Medical Research Network (CNS/psychiatric capabilities) and Chicago Research Center (sleep and CNS research), and serves pharmaceutical sponsors and CROs with high-quality data, diverse patient access, and rapid study startup.

Product and service1 record
1IMA Clinical Research Site Network
Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
1Medical Research Network (MRN)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-01-01
Description

Acquisition in 2025 extending therapeutic reach and capabilities in CNS research and increasing patient access to trials in New York metropolitan market. NYC Uptown location (formerly MRN) focuses on psychiatric disorders including ADHD, depression, psychedelics, panic disorder, GAD, social anxiety disorder, PTSD, bipolar I & II, binge eating disorder.

imaresearch.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-01-01
Description

Acquisition adding specialized CNS and sleep research capabilities including dedicated sleep lab infrastructure to support complex studies. Chicago location has participated in 800+ clinical trials since 2005.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-01-11
Description

Acquired Louisiana-based clinical research company to expand presence in US southeast and enhance trial capabilities. CTA operated as a site network in Monroe, Louisiana.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Pharmaceutical sponsor participating in joint webinar on clinical research KPIs. Sean Cunningham, Senior Director, Study Site Engagement at Takeda, featured as speaker alongside IMA leadership.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

CRO partner participating in joint webinar on clinical research KPIs. Karen McIntyre, VP Global Site Alliances at Parexel, featured as speaker alongside IMA leadership.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Industry organization partnership for webinar programming and site network collaboration. IMA participates in SCRS events including Global Site Solutions Summit and benefits from organization resources and networking.

7Association of Multisite Research Corporations (AMRC)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Founding member of AMRC, an organization advancing the multisite research model and strengthening collaboration, standardization, and quality across the clinical research industry.

imaresearch.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Centricity Research is a North American clinical trial site network operating integrated research sites across the US and Canada. It is a directly comparable multisite research corporation (MRC) competing for the same sponsor and CRO study contracts as IMA Clinical Research.

TypeDirect peer
Description

Evolution Research Group operates a network of clinical trial sites specializing in CNS, early-phase, and specialty therapeutic research across the US. Its multi-site, CNS-focused model closely mirrors IMA's post-MRN/CRC build and targets the same sponsor customer base.

3Aventiv Research
TypeDirect peer
Description

Aventiv Research is a multi-site clinical research organization operating Phase II-IV trials across therapeutic areas including CNS and pain. It is referenced in IMA's leadership bios and competes in the same multisite research corporation category.

4Radiant Research
TypeDirect peer
Description

Radiant Research (now part of alternate ownership structures) is a historical US multisite research site network operating across multiple therapeutic areas. It is referenced in IMA's VP of Patient Recruitment background and represents the same SMO/MRC model.

TypeEmerging player
Description

Flourish Research is an emerging multi-site clinical research platform consolidating US-based research sites across multiple therapeutic areas. It is a partial overlap comparable as a growing SMO/MRC competitor targeting the same sponsor budgets.

TypeBroad incumbent
Description

IQVIA is the largest global CRO with embedded site network (formerly Synexus/PRA) and full Phase I-IV services. It competes with IMA on site selection and site-network contracts as part of broader full-service offerings.

TypeBroad incumbent
Description

ICON is a top-3 global CRO offering clinical research services including site management. Multiple IMA executives previously held senior roles at ICON, reflecting direct competition for both talent and sponsor contracts.

TypeBroad incumbent
Description

Worldwide Clinical Trials is a mid-to-large global CRO providing Phase I-IV clinical trial services. It is a broader incumbent comparable that competes with IMA for Phase II-IV and post-market study contracts from similar pharmaceutical sponsors.

TypeOthers
Description

Parexel is a top global CRO that is both a named customer and partner of IMA Clinical Research, participating in joint webinars. As a CRO customer, it is an ecosystem participant that channels studies to IMA's network rather than a direct site-network competitor.

TypeOthers
Description

CTA was a Louisiana-based clinical trial site network acquired by IMA Group in January 2023. Listed here as an OTHERS reference to illustrate prior comparable site networks IMA has absorbed in its consolidation strategy.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks1 record

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries6 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

IMA Clinical Research

Clinical Research Servicesimaresearch.com

IMA Clinical Research is a US multisite clinical research network within The IMA Group that runs Phase II-IV and decentralized clinical trials for pharmaceutical sponsors and CROs through 90+ full-service sites and 150+ satellite locations, supported by a 400K+ patient database.

What IMA Clinical Research does

IMA Clinical Research is a US-based, multisite clinical research site network operating as the dedicated clinical research division of The IMA Group, which was founded in 1995 by David C. Pulver, MD and has grown from a single office to 90+ offices across 20 states plus the District of Columbia. The company provides Phase II through Phase IV and post-market clinical trials to pharmaceutical sponsors and Contract Research Organizations, delivering trials through site-based, hybrid, and fully decentralized models across 90+ full-service sites and 150+ satellite locations. Its primary customer segments are pharmaceutical sponsors and CROs seeking diverse patient enrollment, rapid study startup, and high-quality data; patients seeking access to investigational treatments represent a secondary, indirect segment served through recruitment.

Core offerings include a fully integrated Clinical Trial Management System (CTMS) platform supporting centralized contracting, feasibility, budget development, IRB submissions, and accounting; a centralized Patient Outreach Center for longitudinal engagement with patients not typically reached onsite; a Patient Portal for remote participation management; and FlexBooker-integrated scheduling across locations. A stated 400K+ patient database with 10K+ unique patients seen weekly underpins recruitment and retention. Therapeutic coverage spans psychiatry, neurology, cardiometabolic, vaccines and infectious disease, gastrointestinal, pain, sleep, and digital therapeutics.

The business model is B2B fee-for-service clinical research, with revenue generated through study contracts negotiated directly with sponsors and CROs on a per-patient enrollment, milestone, and site-operational fee basis. The company is privately held (no public listing), headquartered in Tarrytown, NY (per the office locations data), has 501-1000 employees, and has executed three acquisitions — Clinical Trials of America (January 2023), Medical Research Network (2025), and Chicago Research Center (2025) — to expand CNS/psychiatric and Southeast US capabilities.

IMA Clinical Research firmographics

Firmographics
Name
IMA Clinical Research
Legal name
IMA Clinical Research
Website
https://imaresearch.com
Company type
Private
Founded year
1995
Operating status
Operating
Headcount range
101–250 employees
Short description
IMA Clinical Research is a US multisite clinical research network within The IMA Group that runs Phase II-IV and decentralized clinical trials for pharmaceutical sponsors and CROs through 90+ full-service sites and 150+ satellite locations, supported by a 400K+ patient database.
Ownership category
akta.pro rank

IMA Clinical Research industry classification

Industry
Product category
Clinical Research Services
NAICS
Scientific Research and Development Services (5417)
SIC
Services-Commercial Physical & Biological Research (8731), Services-Health Services (8000)
akta.pro industry
PRIMARYHLAGACAE
Clinical Trial Site Operations & Study Coordination
SECONDARYHLAGACAH
Decentralized & Hybrid Trial Site Services (Home Health/Nursing)
SECONDARYHLAGAAAI
Patient Recruitment, Site Feasibility & Trial Enablement CROs

Keywords

  • Clinical trial services
  • Clinical research sites
  • Patient recruitment services
  • Decentralized clinical trials
  • Contract research organization

Where IMA Clinical Research is headquartered

Location

Headquarters

HQ city
Tarrytown
HQ country
United States
HQ region
North America

Offices14 records

Markets served

IMA Clinical Research business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

  1. Clinical Research Services: Fee-for-service clinical trial conduct providing Phase II-IV and post-market studies for pharmaceutical sponsors and CROs. Revenue generated through study contracts based on per-patient enrollment, study milestones, and site operational fees.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels8 records

IMA Clinical Research product offering

Product offering

Core offering

IMA Clinical Research operates a nationwide clinical trial site network providing Phase II-IV and post-market clinical study conduct for pharmaceutical sponsors and Contract Research Organizations (CROs). Services are delivered through site-based, hybrid, and fully decentralized trial models across 90+ full-service sites and 150+ satellite locations, leveraging a 400K+ patient database and a centralized Patient Outreach Center for enrollment and longitudinal engagement.

Product overview

IMA Clinical Research operates as a flexible clinical trial site network offering site-based, hybrid, and fully decentralized clinical trials. The network consists of 15+ full-service clinical trial sites and 150+ satellite locations across the United States, providing access to over 400,000 patients in a rapidly growing database. Key offerings include: the core IMA Clinical Research Network platform with a fully integrated CTMS for centralized contracting, budgeting, and study management; the Patient Outreach Center for longitudinal patient engagement; a Patient Portal for remote participation management; and comprehensive therapeutic research across psychiatry, neurology, cardiometabolic conditions, vaccines, and other specialties. The company has expanded through strategic acquisitions including Medical Research Network (CNS/psychiatric capabilities) and Chicago Research Center (sleep and CNS research), and serves pharmaceutical sponsors and CROs with high-quality data, diverse patient access, and rapid study startup.

Differentiator

Problem solved

Functional benefit

Products and services

  • IMA Clinical Research Site Network

Quantifiable outcome

  • High enrollment rates through access to 10K+ unique patients weekly
  • +3 more outcomes

Companies that use IMA Clinical Research

Customer profile

Named customers2 records

Segments3 records

Ideal customer profiles2 records

IMA Clinical Research technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability3 records

Feature3 records

IMA Clinical Research partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered core and minor.

  • Medical Research Network (MRN)coreStrategic or Co-development Partner · 1 January 2025Acquisition in 2025 extending therapeutic reach and capabilities in CNS research and increasing patient access to trials in New York metropolitan market. NYC Uptown location (formerly MRN) focuses on psychiatric disorders including ADHD, depression, psychedelics, panic disorder, GAD, social anxiety disorder, PTSD, bipolar I & II, binge eating disorder.
  • Chicago Research CentercoreStrategic or Co-development Partner · 1 January 2025Acquisition adding specialized CNS and sleep research capabilities including dedicated sleep lab infrastructure to support complex studies. Chicago location has participated in 800+ clinical trials since 2005.
  • Clinical Trials of America (CTA)coreStrategic or Co-development Partner · 11 January 2023Acquired Louisiana-based clinical research company to expand presence in US southeast and enhance trial capabilities. CTA operated as a site network in Monroe, Louisiana.
  • TakedaminorStrategic or Co-development PartnerPharmaceutical sponsor participating in joint webinar on clinical research KPIs. Sean Cunningham, Senior Director, Study Site Engagement at Takeda, featured as speaker alongside IMA leadership.
  • ParexelminorStrategic or Co-development PartnerCRO partner participating in joint webinar on clinical research KPIs. Karen McIntyre, VP Global Site Alliances at Parexel, featured as speaker alongside IMA leadership.
  • Society for Clinical Research Sites (SCRS)coreStrategic or Co-development PartnerIndustry organization partnership for webinar programming and site network collaboration. IMA participates in SCRS events including Global Site Solutions Summit and benefits from organization resources and networking.
  • Association of Multisite Research Corporations (AMRC)coreStrategic or Co-development PartnerFounding member of AMRC, an organization advancing the multisite research model and strengthening collaboration, standardization, and quality across the clinical research industry.

Scale indicators9 records

Recent moves6 records

Expansion highlights6 records

IMA Clinical Research competitors and assessment

Company assessment

Direct peers

  • Centricity Research: Centricity Research is a North American clinical trial site network operating integrated research sites across the US and Canada. It is a directly comparable multisite research corporation (MRC) competing for the same sponsor and CRO study contracts as IMA Clinical Research.
  • Evolution Research Group: Evolution Research Group operates a network of clinical trial sites specializing in CNS, early-phase, and specialty therapeutic research across the US. Its multi-site, CNS-focused model closely mirrors IMA's post-MRN/CRC build and targets the same sponsor customer base.
  • Aventiv Research: Aventiv Research is a multi-site clinical research organization operating Phase II-IV trials across therapeutic areas including CNS and pain. It is referenced in IMA's leadership bios and competes in the same multisite research corporation category.
  • Radiant Research: Radiant Research (now part of alternate ownership structures) is a historical US multisite research site network operating across multiple therapeutic areas. It is referenced in IMA's VP of Patient Recruitment background and represents the same SMO/MRC model.

Emerging players

  • Flourish Research: Flourish Research is an emerging multi-site clinical research platform consolidating US-based research sites across multiple therapeutic areas. It is a partial overlap comparable as a growing SMO/MRC competitor targeting the same sponsor budgets.

Broad incumbents

  • IQVIA: IQVIA is the largest global CRO with embedded site network (formerly Synexus/PRA) and full Phase I-IV services. It competes with IMA on site selection and site-network contracts as part of broader full-service offerings.
  • ICON plc: ICON is a top-3 global CRO offering clinical research services including site management. Multiple IMA executives previously held senior roles at ICON, reflecting direct competition for both talent and sponsor contracts.
  • Worldwide Clinical Trials: Worldwide Clinical Trials is a mid-to-large global CRO providing Phase I-IV clinical trial services. It is a broader incumbent comparable that competes with IMA for Phase II-IV and post-market study contracts from similar pharmaceutical sponsors.

Others

  • Parexel: Parexel is a top global CRO that is both a named customer and partner of IMA Clinical Research, participating in joint webinars. As a CRO customer, it is an ecosystem participant that channels studies to IMA's network rather than a direct site-network competitor.
  • Clinical Trials of America (CTA): CTA was a Louisiana-based clinical trial site network acquired by IMA Group in January 2023. Listed here as an OTHERS reference to illustrate prior comparable site networks IMA has absorbed in its consolidation strategy.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks1 record

Key highlights7 records

Customer concentration

IMA Clinical Research social profiles

Digital presence

IMA Clinical Research financial estimates

Financial estimate

Revenue estimate

Valuation estimate

IMA Clinical Research leadership team

Management profile

Number of profiles

Profiles10 records

IMA Clinical Research subsidiaries and ownership

Company hierarchy

Subsidiaries6 records

IMA Clinical Research funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

IMA Clinical Research M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about IMA Clinical Research

What does IMA Clinical Research do?

IMA Clinical Research operates a nationwide clinical trial site network providing Phase II-IV and post-market clinical study conduct for pharmaceutical sponsors and Contract Research Organizations (CROs). Services are delivered through site-based, hybrid, and fully decentralized trial models across 90+ full-service sites and 150+ satellite locations, leveraging a 400K+ patient database and a centralized Patient Outreach Center for enrollment and longitudinal engagement.

Is IMA Clinical Research a public or private company?

IMA Clinical Research is a private company. It is classified as corporate owned and is currently operating.

When was IMA Clinical Research founded?

IMA Clinical Research was founded in 1995. It employs 101 to 250 people.

Where is IMA Clinical Research based?

IMA Clinical Research is headquartered in Tarrytown, United States, in the North America region.

How does IMA Clinical Research make money?

One revenue line is on record: clinical Research Services.

Who are IMA Clinical Research's main competitors?

Direct peers on record are Centricity Research, Evolution Research Group, Aventiv Research and Radiant Research. Flourish Research is listed as an emerging player. Broad incumbents are IQVIA, ICON plc and Worldwide Clinical Trials. Others are Parexel and Clinical Trials of America (CTA).

Does IMA Clinical Research have an API?

No public API is recorded for IMA Clinical Research.

What industry is IMA Clinical Research in?

IMA Clinical Research's product category is Clinical Research Services. Its primary akta.pro industry code is HLAGACAE, Clinical Trial Site Operations & Study Coordination, with a secondary code of HLAGACAH, Decentralized & Hybrid Trial Site Services (Home Health/Nursing). Its NAICS code is 5417 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales